Wednesday 30 October 2019

Reuters Health Report: Bayer says U.S. farmers unfazed by glyphosate litigation

Reuters.com Newsletter

Bayer says U.S. farmers unfazed by glyphosate litigation

Bayer , the world's largest maker of seeds and pesticides, said U.S. farmers were unperturbed by lawsuits seeking damages from Bayer for an alleged cancer-causing effect of glyphosate-based herbicides.

Indonesia hikes state health insurer's premiums to plug deficit

Indonesia's state health insurer will raise regular customers' premiums starting 2020 to patch up deficits and the government will chip in to cover this year's $2.3 billion estimated cash shortfall, according to a government statement on Wednesday.

Exclusive: J&J's own expert, working for FDA, found asbestos in Baby Powder

Ever since Johnson & Johnson disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.

Novartis' Zolgensma study halted by FDA amid safety questions

U.S. regulators have halted a trial of Novartis's Zolgensma treatment after an animal study raised safety concerns, the company said on Wednesday, in a setback for the drugmaker's plan to expand its use to older patients.

AstraZeneca sells European rights for schizophrenia drug to Cheplapharm

AstraZeneca Plc said on Wednesday it plans to sell the European and Russian rights for a schizophrenia drug to German firm Cheplapharm Arzneimittel for an upfront payment of $178 million, as the British drugmaker looks to offload older drugs.

Amgen posts higher biosimilar sales, ends neuroscience program

Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall Street estimates.

J&J says new tests find no asbestos in same baby powder bottle that sparked recall

Johnson & Johnson said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says tested positive for trace amounts of asbestos, a finding the agency stands by.

Federal judge blocks Alabama abortion ban from being enforced

A federal judge blocked Alabama on Tuesday from enforcing the strictest abortion laws in the country, saying the ban on all abortions unless a mother's health was in danger was unconstitutional.

U.S. sanctions on Iran threaten access to certain medicines: report

U.S. sanctions on Iran threaten access by some Iranians to medicines that treat diseases such as cancer and epilepsy, despite exemptions in the measures for imports of humanitarian goods, a report said on Tuesday.

Minority heart failure patients may get less access to specialized ICUs

(Reuters Health) - Heart failure patients who are black, Hispanic or female are less likely than others to be admitted to specialized cardiac units, a disparity that may help explain long-known racial and gender differences in heart failure outcomes, a new study suggests.

Ex-FDA chief Gottlieb sees investment opportunity in 'unloved' antibiotics

As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent years: developing new antibiotics.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS